Related references
Note: Only part of the references are listed.Vitamin E Intake Is Associated with Lower Brain Volume in Haptoglobin 1-1 Elderly with Type 2 Diabetes
Abigail Livny et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Haptoglobin Phenotype Modifies the Influence of Intensive Glycemic Control on Cardiovascular Outcomes
Allie S. Carew et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Should the Haptoglobin Genotype Be Considered in Setting Glycemic Goals for Diabetes Patients?
Tina Costacou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Impact of Vitamin E supplementation on vascular function in haptoglobin genotype stratified diabetes patients (EVAS Trial): a randomised controlled trial
Rinkoo Dalan et al.
NUTRITION & DIABETES (2020)
In a Nutshell: Findings from the Bruneck Study
Stefan Kiechl et al.
GERONTOLOGY (2019)
Haptoglobin Phenotype Is Associated With High-Density Lipoprotein-Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery Disease
Rabea Asleh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Association of haptoglobin phenotype with incident acute myocardial infarction in Chinese patients with type 2 diabetes
Resham L. Gurung et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Genetic determinants of circulating haptoglobin concentration
Nabila Kazmi et al.
CLINICA CHIMICA ACTA (2019)
The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus
Rinkoo Dalan et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL
Hagit Goldenstein et al.
JOURNAL OF DIABETES RESEARCH (2018)
Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study
Nathalie Eckel et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Haptoglobin and haptoglobin genotypes in diabetes: A silver bullet to identify the responders to antioxidant therapy?
Jelena P. Seferovic et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)
Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping
Bradley F. Bale et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
Rabea Asleh et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2018)
CD163, a Hemoglobin/Haptoglobin Scavenger Receptor, After Intracerebral Hemorrhage: Functions in Microglia/Macrophages Versus Neurons
Thomas Garton et al.
TRANSLATIONAL STROKE RESEARCH (2017)
Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study
Jonia Amer Alshiek et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes
Irit Hochberg et al.
CURRENT DIABETES REPORTS (2017)
Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes
Rabea Asleh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Is vitamin E supplementation effective in reducing mortality related to cardiovascular events in people with type 2 diabetes mellitus? A systematic review
Nirav Patel et al.
IJC METABOLIC & ENDOCRINE (2016)
Evidence for beneficial effects of vitamin E
Etsuo Niki
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
Benjamin M. Leon et al.
WORLD JOURNAL OF DIABETES (2015)
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
David M. Nathan
DIABETES CARE (2014)
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
Daniel Lorber
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2014)
Haptoglobin Genotype Is a Consistent Marker of Coronary Heart Disease Risk Among Individuals With Elevated Glycosylated Hemoglobin
Leah E. Cahill et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
N. Sarwar et al.
LANCET (2010)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
DIABETES CARE (2009)
Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart Study
Ryan L. McKimmie et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Vitamin e supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype - A prospective double-blinded clinical trial
Uzi Milman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype
Rabea Asleh et al.
DIABETES (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC)
C. T. Prince et al.
DIABETOLOGIA (2007)
Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype implications for the response to intraplaque hemorrhage and plaque vulnerability
Andrew P. Levy et al.
CIRCULATION RESEARCH (2007)
Vitamin E in the primary prevention of cardiovascular disease and cancer - The Women's Health Study: A randomized controlled trial
IM Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes
AP Levy et al.
DIABETES CARE (2004)
Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes
A Roguin et al.
DIABETES CARE (2003)
Share Paper
